Resource Centre
)
EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
- Biopharma
- EPI2ME
- London Calling
May 20 2025
)
Stepping into the future of nanopore protein sequencing
- Biopharma
- MinION
- GridION
- Multiomics
- Cancer research
- Clinical research
May 19 2025
)
Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes
- Biopharma
- PromethION 2
- Epigenetics
- Gene expression
- Multiomics
- Animal
May 19 2025
)
Masterclass: How to sequence full-length plasmids in your own lab | LC25
- Biopharma
- Microbiology
- Bioinformatics
- Infectious disease
- MinION
- GridION
May 19 2025
)
Pharmacogenomic Oxford Nanopore sequencing of the Twist Alliance Long-Read PGx Panel
- Biopharma
- Pharmacogenomics
- Human genomics
- Clinical research
- Targeted
- Variant calling
May 6 2025
)
A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing
- Biopharma
- Virus
- GridION
April 24 2025
)
Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
- Biopharma
- AAV
- MinION
April 19 2025
)
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
- Biopharma
- Direct analysis
- Amplicons
- Plasmid
- mRNA
- AAV
April 16 2025
)
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
- Biopharma
- mRNA
- Virus
- Infectious disease
April 16 2025
)
Workflow overview: whole-plasmid sequencing
- Biopharma
- Microbiology
- Infectious disease
- Plasmid
- Bacteria
- DNA
April 10 2025
Navigating cell and gene therapy: the benefits of whole-genome profiling
- Biopharma
- AAV
- Plasmid
- Webinar
March 25 2025
)
A rapid approach for linear epitope vaccine profiling reveals unexpected epitope tag immunogenicity
- Biopharma
- Immunology
March 19 2025
)
Workflow overview: bacterial isolate sequencing
- Biopharma
- Bacteria
- Whole genome
- DNA
- Microbiology
- Infectious disease
March 18 2025
)
The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies
- Biopharma
- Cancer research
- MinION
- Immunology
March 5 2025
A single amino acid variant in the variable region I of AAV capsid confers liver de-targeting
- Biopharma
- AAV
- Plasmid
- Amplicons
March 5 2025
)
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
- Biopharma
- AAV
- MinION
- Plasmid
January 21 2025
Contaminating manufacturing plasmids and disrupted vector genomes present in liver tissue following adeno-associated virus gene therapy
- Biopharma
- Human genomics
- AAV
- PromethION
- MinKNOW
January 14 2025
)
Antibiotic-mediated selection of randomly mutagenised and cytokine-expressing oncolytic viruses
- Biopharma
- Cancer research
- Virus
- MinION
November 28 2024
)
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations
- Biopharma
- Long-read
- Structural variation
November 27 2024